You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Johnson and Johnson

Last Updated: July 2, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Acetamide

Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Acetamide?

Acetamide is an investigational drug.

There have been 14 clinical trials for Acetamide. The most recent clinical trial was a Phase 2 trial, which was initiated on August 15th 2018.

The most common disease conditions in clinical trials are Cognition Disorders, Acute Pain, and Lymphoma. The leading clinical trial sponsors are California Pacific Medical Center Research Institute, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), and The University of Hong Kong.

There are three US patents protecting this investigational drug and thirty-four international patents.

Recent Clinical Trials for Acetamide
Senicapoc and Dehydrated StomatocytosisQuest DiagnosticsPhase 3
Senicapoc and Dehydrated StomatocytosisBoston Children’s HospitalPhase 3
Modafinil's Effects on Cognition in Remitted MDDOntario Ministry of Health and Long Term CarePhase 3

See all Acetamide clinical trials

Clinical Trial Summary for Acetamide

Top disease conditions for Acetamide
Top clinical trial sponsors for Acetamide

See all Acetamide clinical trials

US Patents for Acetamide

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Acetamide   Start Trial Method for processing silver halide color photographic material for prints Fuji Photo Film Co., Ltd. (Kanagawa, JP)   Start Trial
Acetamide   Start Trial 1-aryl-1-hydroxy-1-substitute d-3-(4-substituted-1-piperazinyl)-2-propanones and their use in treatment of neurogenic bladder disorders Marion Laboratories, Inc. (Kansas City, MO)   Start Trial
Acetamide   Start Trial 7-substituted bicyclic pyrazolidinones Eli Lilly and Company (Indianapolis, IN)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.